- Home
- HEPA vs ADD Comparison
HEPA vs ADD Comparison
Compare HEPA & ADD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- ADD
- Stock Information
- Founded
- HEPA 2013
- ADD 2002
- Country
- HEPA United States
- ADD United States
- Employees
- HEPA N/A
- ADD N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- ADD Engineering & Construction
- Sector
- HEPA Health Care
- ADD Consumer Discretionary
- Exchange
- HEPA Nasdaq
- ADD Nasdaq
- Market Cap
- HEPA 463.4K
- ADD 476.0K
- IPO Year
- HEPA N/A
- ADD N/A
- Fundamental
- Price
- HEPA $0.40
- ADD $0.89
- Analyst Decision
- HEPA
- ADD
- Analyst Count
- HEPA 0
- ADD 0
- Target Price
- HEPA N/A
- ADD N/A
- AVG Volume (30 Days)
- HEPA 4.6M
- ADD 1.9M
- Earning Date
- HEPA 05-20-2025
- ADD 06-02-2025
- Dividend Yield
- HEPA N/A
- ADD N/A
- EPS Growth
- HEPA N/A
- ADD N/A
- EPS
- HEPA N/A
- ADD N/A
- Revenue
- HEPA N/A
- ADD $2,830,442.00
- Revenue This Year
- HEPA N/A
- ADD N/A
- Revenue Next Year
- HEPA N/A
- ADD N/A
- P/E Ratio
- HEPA N/A
- ADD N/A
- Revenue Growth
- HEPA N/A
- ADD N/A
- 52 Week Low
- HEPA $0.25
- ADD $0.56
- 52 Week High
- HEPA $70.00
- ADD $185.00
- Technical
- Relative Strength Index (RSI)
- HEPA 29.59
- ADD 53.08
- Support Level
- HEPA $0.27
- ADD $0.78
- Resistance Level
- HEPA $0.49
- ADD $1.10
- Average True Range (ATR)
- HEPA 0.06
- ADD 0.10
- MACD
- HEPA 0.15
- ADD 0.04
- Stochastic Oscillator
- HEPA 60.54
- ADD 56.83
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.